Inactive Instrument
Precision Therapeutics Inc Stock Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 129M 112M 106M 95.74M 180M 12.37B 181M 1.25B 482M 6.29B 486M 476M 19.88B | P/E 2024 |
-0.35x | P/E 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 120M 104M 98.18M 88.99M 167M 11.5B 168M 1.17B 448M 5.85B 452M 442M 18.48B | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
94.39% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 129M | ||
| -0.71% | -6.35% | -2.99% | +9.59% | 45.48B | ||
| +0.21% | -2.98% | +337.74% | +519.55% | 43.68B | ||
| +1.74% | -2.24% | +39.82% | +20.76% | 43.09B | ||
| +1.38% | -3.28% | +6.84% | +67.62% | 39.4B | ||
| -1.44% | -5.26% | +8.97% | +39.76% | 31.91B | ||
| +0.87% | -2.60% | - | - | 17.31B | ||
| +0.75% | -0.64% | +19.75% | +110.17% | 16.4B | ||
| -0.31% | -2.78% | +10.78% | +31.02% | 14.24B | ||
| +1.93% | -3.55% | +82.00% | +41.17% | 13.28B | ||
| Average | -0.31% | -3.20% | +62.86% | +104.96% | 29.42B | |
| Weighted average by Cap. | +0.41% | -3.50% | +74.57% | +124.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.62M 1.4M 1.32M 1.2M 2.25M 155M 2.26M 15.73M 6.05M 78.92M 6.1M 5.96M 249M | 125K 108K 102K 92.64K 174K 11.97M 175K 1.21M 467K 6.09M 471K 460K 19.24M |
| Net income | -12.66M -10.91M -10.33M -9.36M -17.57M -1.21B -17.66M -123M -47.19M -616M -47.56M -46.52M -1.95B | -233M -201M -190M -172M -323M -22.27B -325M -2.26B -869M -11.33B -875M -856M -35.8B |
| Net Debt | 1.4M 1.2M 1.14M 1.03M 1.94M 133M 1.95M 13.53M 5.2M 67.87M 5.24M 5.13M 214M | -9.12M -7.86M -7.44M -6.75M -12.66M -872M -12.72M -88.41M -34M -443M -34.27M -33.52M -1.4B |
Employees
-
















